Shares of ReShape Lifesciences Inc. (OTCMKTS:RSLSD – Get Free Report) rose 2.3% during trading on Monday . The stock traded as high as $5.37 and last traded at $5.37. Approximately 6,500 shares changed hands during trading, an increase of 377% from the average daily volume of 1,362 shares. The stock had previously closed at $5.25.
ReShape Lifesciences Stock Performance
The company has a current ratio of 1.17, a quick ratio of 1.07 and a debt-to-equity ratio of 0.05. The stock has a 50-day moving average of $5.37.
About ReShape Lifesciences
ReShape Lifesciences Inc, a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy.
Featured Articles
- Five stocks we like better than ReShape Lifesciences
- Investing in the High PE Growth Stocks
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What is a Death Cross in Stocks?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What is the Dogs of the Dow Strategy? Overview and Examples
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.
